Residual cholesteatoma of the temporal bone in a patient with granulomatosis with polyangiitis

A case of residual temporal bone cholesteatoma in a patient with granulomatosis with polyangiitis (Wegener) (GPA) is presented. At the onset of the disease, the patient developed a symptom complex, which included, along with sinonasal manifestations, left-sided purulent otitis media, refractory to traditional therapy. A separate atticoanthrotomy on the left temporal bone, performed in the active phase, before the diagnosis of vasculitis, did not lead to a clinical improvement in the condition of the middle ear. Despite the subsequent implementation of adequate immunosuppressive therapy and drug remission of GPA, the continuously recurrent course of purulent otitis media of the operated ear contributed to the development of residual cholesteatoma of the temporal bone with the spread of the process to surrounding structures. The presence of cholesteatoma was confirmed by MRI of the temporal bones in the non-EPI DWI mode. During the period of drug remission of GPA, repeated sanitizing surgery was performed on the middle ear with tympanoplasty and obliteration of the parathympanic spaces, which made it possible to achieve remission of purulent otitis media. The development of residual middle ear cholesteatoma in a patient with GPA could be due to the untimely initial diagnosis, the late onset of specific immunotherapy, the rapidly progressive and recurrent nature of the course of the disease, and surgical treatment in the phase of high disease activity. The insufficient volume of primary surgical treatment contributed to the formation of laced cavities and the development of residual cholesteatoma of the temporal bone. The use of MRI in the non-EPI DWI mode for diagnosis made it possible to identify the development of cholesteatoma of the left temporal bone in a patient with GPA and track the results of surgical treatment in the postoperative period. The non-EPI DWI MRI method proved effective both for detecting temporal bone cholesteatoma and tracking changes in the postoperative period of a patient with GPA. Tympanoplasty with surgical obliteration of the parathympanic spaces allowed to stop the inflammation of the middle ear in a patient with a systemic autoimmune disease.

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. https://doi.org/10.1002/art.37715.

2. Бекетова ТВ, Насонов ЕЛ (ред.). АНЦА-ассоциированные системные васкулиты. 2014; 44 с. Режим доступа: https://www.researchgate.net/publication/282158422_ANCA-_associated_systemic_vasculitis.

3. Erickson VR, Hwang PH. Wegener’s granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2007;15(3):170-176. https://doi.org/10.1097/M00.0b013e3281568b96.

4. Nicklasson B, Stangeland N. Wegener’s granulomatosis presenting as otitis media. J Laryngol Otol. 1982;96(3):277-280. https://doi.org/10.1017/S0022215100092501.

5. Smirnova IG, Bulanov NM, Novikov PI, Moiseev SV. Upper respiratory tract involvement in patients with ANCA-associated vasculitis. Clinical Pharmacology and Therapy. 2019;28(4):65-75. (In Russ.) https://doi.org/10.32756/0869-5490-2019-4-65-75.

6. Gottschlich S, Ambrosch P, Kramkowski D, Laudien M, Buchelt T, Gross WL, Hellmich B. Head and neck manifestations of Wegener’s granulomatosis. Rhinology. 2006;44(4):227-233. Available at: https://pubmed.ncbi.nlm.nih.gov/17216737/.

7. Harabuchi Y, Kishibe K, Komabayashi Y. Clinical manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis) in the upper respiratory tract seen by otolaryngologists in Japan. Clin Exp Nephrol. 2013;17(5):663-666. https://doi.org/10.1007/s10157-012-0768-2.

8. Takagi D, Nakamaru Y, Maguchi S, Furuta Y, Fukuda S. Otologic manifestations of Wegener’s granulomatosis. Laryngoscope. 2002;112(9):1684-1690. https://doi.org/10.1097/00005537-200209000-00029.

9. Harabuchi Y, Kishibe K, Tateyama K, Morita Y, Yoshida N, Okada M et al. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society. Auris Nasus Larynx. 2021;48(1):2-14. https://doi.org/10.1016/j.anl.2020.07.004.

10. Wojciechowska J, Krajewski W, Krajewski P, Kr^cicki T. Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge. Clin Exp Otorhinolaryngol. 2016;9(1):8-13. https://doi.org/10.21053/ceo.2016.9.1.8.

11. Drinias V, Florentzson R. Facial palsy and Wegener’s granulomatosis. Am J Otolaryngol. 2004;25(3):208-212. https://doi.org/10.1016/j.amjoto.2003.11.007.

12. Magliulo G, Parrotto D, Alla FR, Gagliardi S. Acute bilateral facial palsy and Wegener’s disease. Otolaryngol Head Neck Surg. 2008;139(3):476-477. https://doi.org/10.1016/j.otohns.2008.04.010.

13. Toth I, Kaszas B, Horvath G, Piski Z, Bako P, Lujber L. Modern management of otologic consequences of Wegener’s granulomatosis a case report and review of the literature. Orv Hetil. 2019;160(4):151-157. https://doi.org/10.1556/650.2018.31266.

14. Roszkowska A, MorawskaKochman M, Temporale H, Sikorska-Zuk M, Kr^cicki T. Bilateral facial palsy in rapidly progressive course of Wegener’s granulomatosis: a case report. Case Rep Otolaryngol. 2013;2013:875108. https://doi.org/10.1155/2013/875108.

15. Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol. 2000;21(6):793-798. https://doi.org/10.1155/2013/875108.

16. Sanna M, Sunose H, Mancini F, Russo A, Taibah A. Middle ear and Mastoid Microsurgery. Stuttgart-New York: Georg Thieme Verlag; 2003. 612 p. https://doi.org/10.1055/b-002-52055.

17. Wilson KF, London NR, Shelton C. Tympanoplasty with intact canal wall mastoidectomy for cholesteatoma: long-term hearing outcomes. Laryngoscope. 2013;123(12):3168-3171. https://doi.org/10.1177/0194599813489521.

18. Fisch U, Schmid S. Total reconstruction of the ossicular chain. Otolaryngol Clin North Am. 1994;27(4):785-797. https://doi.org/10.1016/S00306665(20)30647-2.

19. Dornhoffer JL. Retrograde mastoidectomy with canal wall reconstruction: a single-stage technique for cholesteatoma removal. Ann Otol Rhinol Laryngol. 2000;109(11):1033-1039. https://doi.org/10.1177/000348940010901108.

20. Ognetov SY, Kravchuk AP. Recurrent and residual cholesteatoma rates after different types of sanitation surgery on middle ear. Kazan Medical Journal. 2016;97(3):367-370. (In Russ.) https://doi.org/10.17750/KMJ2016-367.

21. Karmarkar S, Bhatia S, Saleh E, DeDonato G, Taibah A, Russo A, Sanna M. Cholesteatoma surgery: the individualized technique. Ann Otol Rhinol Laryngol. 1995;104(8):591-595. https://doi.org/10.1177/000348949510400801.

22. Hartwein J, Hermann K. A technique for the reconstruction of the posterior canal wall and mastoid obliteration in radical cavity surgery. Am J Otol. 1990;11(3):169-173. Available at: https://pubmed.ncbi.nlm.nih.gov/2343900/.

23. Lee WS, Kim SH, Lee WS, Kim SH, Moon IS, Byeon HK. Canal wall reconstruction and mastoid obliteration in canal wall down tympanomastoidectomized patients. Acta Otolaryngol. 2009;129(9):955-961. https://doi.org/10.1080/00016480802510178.

24. Stoor P, Pulkkinen J, Grenman R. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Ann Otol Rhinol Laryngol. 2010;119(6):377-382. https://doi.org/10.1177/000348941 011900603.

25. Lingam RK, Khatri P, Hughes J, Singh A. Apparent diffusion coefficients for detection of postoperative middle ear cholesteatoma on non-echo-planar diffusion-weighted images. Radiology. 2013;269(2):504-510. https://doi.org/10.1148/radiol.13130065.

26. Locketz GD, Li PM, Fischbein NJ, Holdsworth SJ, Blevins NH. Fusion of Computed Tomography and PROPELLER Diffusion-Weighted Magnetic Resonance Imaging for the Detection and Localization of Middle Ear Cholesteatoma. JAMA Otolaryngol Head Neck Surg. 2016;142(10):947-953. https://doi.org/10.1001/jamaoto.2016.1663.

27. Li PM, Linos E, Gurgel RK, Fischbein NJ, Blevins NH. Evaluating the utility of non-echo-planar diffusion-weighted imaging in the preoperative evaluation of cholesteatoma: a meta-analysis. Laryngoscope. 2013;123(5):1247-1250. https://doi.org/10.1002/lary.23759.

28. Profant M, Slavikova K, Kabatova Z, Slezak P,Waczuli'kova I. Predictive validity of MRI in detecting and following cholesteatoma. Eur Arch Otorhinolaryngol. 2012;269(3):757-765. https://doi.org/10.1007/s00405-011-1706-8.

29. Kosyakov SY, Pchelenok EV. The modern approaches to the treatment of chronic suppurative otitis with cholesteatoma. Vestnik Oto-Rino-Laringologii. 2014;(6):4-7. (In Russ.) http://doi.org/10.17116/otorino201464-7.

30. Kosyakov SY, Pchelenok EV. The results of surgical ablation of parathympanic spaces in the patients presenting with cholesteatoma. Vestnik OtoRinoLaringologii. 2018;83(6):22-26. (In Russ.) https://doi.org/10.17116/otorino20188306122.